The DOI matches its Crossref record.
Adrenergic Modulation of Basal Insulin Secretion in Man
Abstract
In normal men of varying degrees of adiposity, alphaadrenergic blockade (one-hour intravenous infusion with phentolamine, 0.5 mg./min.) produced a 31 ± 23 per cent (mean ± S.D.) increase (n = 6, p < .02) over basal insulin levels whereas beta-adrenergic blockade (one-hour intravenous infusion with propranolol, 0.08 mg./min.) produced a 38 ± 15 per cent decrease (n = 6, p < .002) from basal insulin levels; basal glucose did not change during either type of blockade. Epinephrine (two-hour intravenous infusion, 6 /tg./min.) produced a 46 ± 8 per cent decrement in basal insulin by 7 ± 4 min. (n = 12, p < .001). This was followed by a period of recovery during which insulin levels rose to control levels by 46 ± 26 minutes and to 166 ± 36 per cent of control (p < .001) by two hours. The nadir of the decrement correlated, with a high degree of statistical significance, with basal insulin values (r = .99, p < .001), and the amount of time required during the recovery phase for insulin levels to rise to control levels correlated highly with the nadir of the decrement (r = .83, p < .001). The epinephrine-induced decrement from basal insulin did not occur in three subjects pretreated with phentolamine but did occur in four subjects pretreated with propranolol. In the four subjects pretreated with propranolol, the mean recovery time during epinephrine infusion was seventy-two minutes, compared to thirty-six minutes for the group receiving epinephrine alone. In four separate studies, propranolol was superimposed after two hours of a three-hour epinephrine infusion had elapsed, and the elevated insulin levels that had developed by two hours promptly fell below basal levels. It is concluded that (1) endogenous adrenergic activity modulates basal insulin secretion; (2) increases in circulating epinephrine prompt a rapid, marked fall in basal insulin which is alpha mediated; and (3) a slower, beta-mediated recovery phase follows during which insulin surpasses basal levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109464 · Cited by 421
Synergistic Interactions of Physiologic Increments of Glucagon, Epinephrine, and Cortisol in the Dog
Eigler, N., Saccà, L., & Sherwin, R. S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109264 · Cited by 260
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle, M. E., & Egan, J. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.7 · Cited by 256
Sham feeding-induced cephalic phase insulin release in the rat
Berthoud, H. R., & Jeanrenaud, B. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.242.4.e280 · Cited by 103
Dornhorst, A., Powell, S., & Pensky, J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91900-2 · Cited by 100
Metadata
- Authors
- Robertson, R. P., & Porte, D.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1973-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2144499256
- Cited by
- 209
- References
- 0
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenergic Modulation of Basal Insulin Secretion in Man. https://app.cochat.ai/papers/10.2337/diab.22.1.1
- The paper
- Robertson, R. P., & Porte, D. (1973). Adrenergic Modulation of Basal Insulin Secretion in Man. Diabetes. https://doi.org/10.2337/diab.22.1.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.